| Synonyms: | |
| Status: | Approved (1946) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | D04AA32 |
| UNII: | 8GTS82S83M |
| InChI Key | ZZVUWRFHKOJYTH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H21NO |
| Molecular Weight | 255.36 |
| AlogP | 3.35 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 12.47 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 19.0 |
| Primary Target | |
|---|---|
| H1 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 2570-26915 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 41000 | - | - | 60 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | 1 | 12 | 15 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pain | 3 | D010146 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Kidney Diseases | 3 | D007674 | ClinicalTrials |
| Migraine Disorders | 3 | D008881 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Urticaria | 3 | D014581 | ClinicalTrials |
| Lupus Nephritis | 3 | D008181 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Cough | 3 | D003371 | ClinicalTrials |
| Inflammation | 3 | D007249 | ClinicalTrials |
| Rhinitis | 3 | D012220 | ClinicalTrials |
| Stomatitis | 3 | D013280 | ClinicalTrials |
| Stomatitis | 3 | D013280 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054218 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Leukemia, T-Cell | 2 | D015458 | ClinicalTrials |
| Breast Carcinoma In Situ | 2 | D000071960 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Stomatitis, Aphthous | 2 | D013281 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Restless Legs Syndrome | 2 | D012148 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Leukemia, Mast-Cell | 2 | D007946 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Immunoglobulin G4-Related Disease | 2 | D000077733 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| alpha 1-Antitrypsin Deficiency | 1 | D019896 | ClinicalTrials |
| Crohn Disease | 1 | D003424 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 1 | D016553 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 1 | D000744 | ClinicalTrials |
| Glycogen Storage Disease Type II | 1 | D006009 | ClinicalTrials |
| Immune System Diseases | 1 | D007154 | ClinicalTrials |
| Fibrosis | 1 | D005355 | ClinicalTrials |
| Depressive Disorder, Major | 1 | D003865 | ClinicalTrials |
| Dermatitis, Atopic | 0 | D003876 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 58-73-1 |
| ChEBI | 4636 |
| ChEMBL | CHEMBL657 |
| DrugBank | DB01075 |
| DrugCentral | 916 |
| EPA CompTox | DTXSID4022949 |
| FDA SRS | 8GTS82S83M |
| Human Metabolome Database | HMDB0001927 |
| Guide to Pharmacology | 1224 |
| KEGG | C06960 |
| PDB | 2PM |
| PharmGKB | PA449349 |
| PubChem | 3100 |
| SureChEMBL | SCHEMBL4064 |
| ZINC | ZINC000000020244 |